Desjardins Global Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.45M Sell
43,651
-4,010
-8% -$285K 0.37% 49
2023
Q3
$3.33M Buy
47,661
+19,868
+71% +$1.41M 0.36% 56
2023
Q2
$1.92M Buy
27,793
+5,109
+23% +$364K 0.22% 99
2023
Q1
$1.69M Buy
22,684
+1,972
+10% +$165K 0.21% 100
2022
Q4
$1.93M Sell
20,712
-26,731
-56% -$2.58M 0.3% 65
2022
Q3
$4.52M Sell
47,443
-3,963
-8% -$392K 0.57% 23
2022
Q2
$4.76M Sell
51,406
-17,317
-25% -$1.69M 0.63% 25
2022
Q1
$6.96M Sell
68,723
-5,048
-7% -$530K 0.61% 30
2021
Q4
$7.61M Buy
+73,771
New +$6.82M 0.65% 25

Other funds holding CVS

Desjardins Global Asset Management's CVS Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its CVS Health (CVS) stake by 8.4% in Q4 2023, selling an estimated $285K and leaving 43,651 shares worth $3.45M. The position accounts for 0.37% of the portfolio, ranked #49.

Desjardins Global Asset Management first reported a position in CVS in Q4 2021 and has held it in 9 quarters since. The position peaked at $7.61M in Q4 2021. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Desjardins Global Asset Management held 43,651 shares of CVS Health worth $3.45M as of Q4 2023.
  • Desjardins Global Asset Management sold 4,010 CVS Health shares in Q4 2023, an estimated $285K.
  • CVS Health made up 0.37% of Desjardins Global Asset Management's portfolio in Q4 2023, its #49 holding.
  • Desjardins Global Asset Management first reported a position in CVS Health in Q4 2021 and has held it in 9 quarters since.
  • Desjardins Global Asset Management's CVS Health position peaked at $7.61M in Q4 2021.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.